Literature DB >> 3231130

Relationship between susceptibility and immune response to staphylococcal exfoliative toxin A in mammalian species.

K Machida1, S Sakurai, I Kondo, S Ikawa.   

Abstract

Staphylococcal exfoliative toxin A (ETA) had a splitting effect at the granular layer of skin in humans and neonatal mice, but not in rabbits, guinea pigs, golden hamsters, or rats. Besides its splitting effect, ETA could stimulate productions of neutralizing antibody to ETA in rabbits, rats and B10D2 mice, but not in golden hamsters, guinea pigs, or ICR, HRS/J, and C57BL/10 mice. In our epidemiological investigation of human sera, the percentage of antibody to ETA in sera obtained from patients with impetigo (8%) was lower than those in sera of healthy males (23%) and females (29%). The relationship between susceptibility and immune response to ETA in these mammalians could be divided into three groups: the possession of resistant skin and high production of antibody to ETA; the possession of resistant skin and low production of antibody to ETA; the possession of sensitive skin and various titers of antibody to ETA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3231130     DOI: 10.1111/j.1348-0421.1988.tb01472.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  A new type of staphylococcal exfoliative toxin from a Staphylococcus aureus strain isolated from a horse with phlegmon.

Authors:  H Sato; Y Matsumori; T Tanabe; H Saito; A Shimizu; J Kawano
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

2.  Purification of exfoliative toxin produced by Staphylococcus hyicus and its antigenicity.

Authors:  T Tanabe; H Sato; M Kuramoto; H Saito
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

Review 3.  Exfoliative toxins of Staphylococcus aureus.

Authors:  Michal Bukowski; Benedykt Wladyka; Grzegorz Dubin
Journal:  Toxins (Basel)       Date:  2010-05-25       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.